Suicidality

SIBAT—A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties
by Larry Alphs, MD, PhD; Dong-Jing Fu, MD, PhD; David Williamson, PhD; Carol Jamieson, BSc, FIBMS; John Greist, MD; Magdalena Harrington, PhD; Jean-Pierre Lindenmayer, MD; Cheryl McCullumsmith, MD, PhD; David V. Sheehan, MD, MBA; Richard C. Shelton, MD; Paul Wicks, PhD; and Carla M. Canuso, MD, on behalf of the SIBAT Consortium Dr. Alphs is with […]

Selective Serotonin Reuptake Inhibitors (SSRIs) and Their Effect on Patient Aggression in Adult Patients in a State Psychiatric Facility: A Retrospective Analysis
by Carolyn O’Donnell, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN; Drs. O’Donnell, Demler, and Trigoboff are with the State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice in Buffalo, New York. Drs. O’Donnell and Demler are with the New York State […]

Is Transcranial Magnetic Stimulation Appropriate For Treating Adolescents with Depression?
by Puneet Narang, MD; Katelyn Madigan, BS; Simrat Sarai, MD; and Steven Lippmann, MD Dr. Narang is with the University of Minnesota and Regions Hospital, Minneapolis–St. Paul in Minneapolis, Minnesota. Ms. Madigan is with the University of Minnesota, Minneapolis–St. Paul in Minneapolis, Minnesota. Drs. Sarai and Lippmann are with the University of Louisville School of […]

Lithium Suicide Prevention: A Brief Review and Reminder
by Simrat Kaur Sarai, MD; Hema Madhuri Mekala, MD; and Steven Lippmann, MD Drs. Sarai and Mekala are research scholars and Dr. Lippmann is Emeritus Professor for the Department of Psychiatry and Behavioral Sciences at University of Louisville School of Medicine in Louisville, Kentucky. Funding: No funding was provided. Disclosures: The authors have no conflicts […]

Risk Management: My Patient Suicided, Now What?
by Donna Vanderpool, MBA, JD Ms. Vanderpool is Vice President at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee of PRMS Inc., a risk management consulting company for healthcare providers. Innov Clin Neurosci. 2018;15(9–10):30–31 This ongoing column is dedicated to providing […]

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)
By Clare Brennan, DPT, MSPH; Hannah Whillis, MS; Choy Man, BS; Brian Wynne, MD; Vani Vannappagari, MBBS, MPH, PhD Dr. Brennan and and Ms. Man are with Clinical Development and Dr. Vannappagari is with Epidemiology and Real World Evidence at ViiV Healthcare in Research Triangle Park, North Carolina. Ms. Whillis was with GlaxoSmithKline, plc, in […]

Single Nucleotide Polymorphisms and the Central Nervous System: Potential Biomarkers in Identifying Suicide Risk
by Atmaram Yarlagadda, MD; Kevin P. Rosenblatt, MD, PhD; and Anita H. Clayton, MD Dr. Yarlagadda is Chief, Behavioral Health Services, McDonald Army Health Center in Newport News, Virginia, and Assistant Professor, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia; Dr. Rosenblatt is Adjunct Associate Professor, UT Health at Houston, Department of […]

A Case of Treatment-resistant Depression and Body Dysmorphic Disorder: The Role of Electroconvulsive Therapy Revisited
by Ram S. Mahato, MD; Maria Chona P. San Gabriel, MD; Carrol T. Longshore, MD; and David B. Schnur, MD The authors are with the Department of Psychiatry at Elmhurst Hospital Center, Icahn School of Medicine at Mount Sinai, Elmhurst, New York. Innov Clin Neurosci. 2016;13(7–8):37–40. Funding: No funding was received for the preparation of […]